Recruiting Diffuse Large B-Cell Lymphoma Studies in Tucson
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment ...
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin helps benefit patients who have received chemotherapy (fludarabine and cyclophosphamide) followed by chimeric antigen recepto...
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
A multicenter, open-label Phase 2b study of selinexor (KPT-330) in participants with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) who have no therapeutic options of demonstrated cli...
About Diffuse Large B-Cell Lymphoma Clinical Trials in Tucson
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, accounting for about 30% of cases. It is an aggressive lymphoma that grows rapidly. Treatment usually involves chemoimmunotherapy, with CAR-T cell therapy for relapsed cases.
There are currently 3 diffuse large b-cell lymphoma clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 1,686 participants. Research is being sponsored by Merck Sharp & Dohme LLC, SWOG Cancer Research Network, Karyopharm Therapeutics Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Diffuse Large B-Cell Lymphoma Clinical Trials in Tucson — FAQ
Are there diffuse large b-cell lymphoma clinical trials in Tucson?
Yes, there are 3 diffuse large b-cell lymphoma clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tucson?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.
Are clinical trials in Tucson free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.
What diffuse large b-cell lymphoma treatments are being tested?
The 3 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for diffuse large b-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov